wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50207951-40DEC83C-398E-4673-B2E4-B8C650CB8644
Q50207951-40DEC83C-398E-4673-B2E4-B8C650CB8644
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50207951-40DEC83C-398E-4673-B2E4-B8C650CB8644
Developing new pharmacotherapeutic approaches to treating sickle-cell disease.
P2860
Q50207951-40DEC83C-398E-4673-B2E4-B8C650CB8644
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50207951-40DEC83C-398E-4673-B2E4-B8C650CB8644
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4d735f569789a1a2926c7f5d511bb8f21135599a
P2860
Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson